KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 56 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $18,000 | -77.8% | 985 | -76.1% | 0.00% | – |
| Q4 2020 | $81,000 | +252.2% | 4,113 | +232.2% | 0.00% | – |
| Q3 2020 | $23,000 | -34.3% | 1,238 | -18.6% | 0.00% | – |
| Q2 2020 | $35,000 | +75.0% | 1,520 | -14.2% | 0.00% | – |
| Q4 2019 | $20,000 | +100.0% | 1,772 | +44.9% | 0.00% | – |
| Q3 2019 | $10,000 | -37.5% | 1,223 | +4.2% | 0.00% | – |
| Q2 2019 | $16,000 | +433.3% | 1,174 | +1176.1% | 0.00% | – |
| Q4 2018 | $3,000 | +200.0% | 92 | +104.4% | 0.00% | – |
| Q3 2018 | $1,000 | -99.4% | 45 | -99.5% | 0.00% | – |
| Q2 2018 | $156,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |